So, future studies using a cohort design with active comparators, such as metformin or DPP4i, would help validate our findings
Hector Perez, MD, lead bariatric surgeon at Renew Bariatrics and an advisor at Bariatric Reports, told Healthline that when it comes to weight loss, its too early to call survodutide a game-changer. [W]hile the reported weight loss number is impressive, we already have very strong performers in this category, he said
Get in touch for more information
#PharmaStrategy #DrugPricing #MarketAccess #340B To view or add a comment, sign in Fee-for-service medicine rewards volume
Our medical providers conduct comprehensive evaluations to determine if GLP-1 therapy is appropriate for your individual situation
Semaglutide commonly causes nausea, vomiting, and reduced appetiteespecially during dose escalation